September 2014

Journal

213Bi-DOTATOC receptor-targeted alph-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

By:
Boll, Rose A; Kratochwil, Clemens; Giesel, F.L.; Mier, W; Haberkorn, U; Bruchertseifer, Frank; Apostolidis, C.; Morgenstern, A.
Journal Name:
European Journal of Nuclear Medicine
Page Number:
1
Volume:
n/a
Issue Number:
n/a
Publication Date:
September 23, 2014